Volume 22, Number 9—September 2016
Research
Ebola Virus Disease, Democratic Republic of the Congo, 2014
Table 1
Characteristic | Total | Male | Female | p value |
---|---|---|---|---|
Sex, no. (%) | 25 (100) | 13 (52) | 12 (48) | |
Median age, y (IQR) |
32 (10–39) |
32 (12–47) |
25 (6.5–38.5) |
0.03 |
Age group, y, no. (%) | ||||
<5 | 4 (16.0) | 1 (7.7) | 3 (25.0) | |
>5 to <15 | 5 (20.0) | 3 (23.1) | 2 (16.7) | |
>15 to <45 | 11 (44.0) | 5 (38.4) | 6 (50.0) | |
>45 |
5 (20.0) |
4 (30.8) |
1 (8.3) |
|
Patient cycle threshold at admission, no. (mean ± SD) | 23 (29.22 ± 5.90) | 12 (30.61 ± 5.39) | 11 (27.7 ± 6.32) | |
<5 y | 3 (22.07 ± 3.63) | <0.001 | ||
>5 to <15 y | 5 (35.06 ± 4.64) | |||
>15 to <45 y | 10 (28.17 ± 4.23) | <0.001 | ||
>45 y |
5 (29.76 ± 6.25) |
|||
Time from onset to admission, mean d ± SD | 4.69 ± 2.63 | 4.61 ± 2.93 | 4.82 ± 2.34 | |
Survived | 4.25 ± 3.13 | |||
Died |
5.21 ± 1.95 |
|||
Median hospital stay, d (IQR) | 4 (3–12) | |||
Survived | 10 (3–13) | 3 | 24 | 0.09 |
Died |
4 (2.5–5.5) |
1 |
18 |
|
Time from onset to outcome, d (IQR) | 10 (7–15) | 3 | 30 | |
Survived | 11.5 (7.5–19.5) | 4 | 30 | 0.28 |
Died | 9 (7–12) | 3 | 23 |
*Blank cells indicate the numbers were too small for meaningful calculation. IQR, interquartile range.
Page created: August 16, 2016
Page updated: August 16, 2016
Page reviewed: August 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.